Gabriele Giuliano

Gabriele Giuliano

Auto-generated profile, based on publicly available information

Gabriele Giuliano

Dipartimento di Biotecnologie Mediche, Università degli Studi di Siena, Siena, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in International Journal of Antimicrobial Agents
Verified
Journal Article
Open access
ETEnrico Maria Trecarichi
Enrico Maria Trecarichi
GGGabriele Giuliano
Gabriele Giuliano
CCChiara Cattaneo
Chiara Cattaneo
SBStelvio Ballanti
Stelvio Ballanti
MCMarianna Criscuolo
Marianna Criscuolo
MTMario Tumbarello
Mario Tumbarello
Bloodstream infections (BSI) caused by Gram-negative bacteria (GNB) in patients with hematological malignancies (HM) have been associated with high mortality rates, particularly with infections caused by antibiotic-resistant strains. A multicenter cohort study including all consecutive episodes of GNB BSI in HM patients was conducted to update the epidemiology and antibiotic resistance patterns (compared to our previous survey conducted between 2009 and 2012) and investigate risk factors for GNB BSI due to multidrug-resistant (MDR) isolates. A total of 834 GNB were recovered in 811 BSI episodes from January 2016 to December 2018. Compared to the previous survey, there was a significant reduction in use of fluoroquinolone prophylaxis and a significant recovery in susceptibility rates to ciprofloxacin among Pseudomonas aeruginosa, Escherichia coli and Enterobacter cloacae isolates. In addition, there was a shift to a significantly increased susceptibility of P. aeruginosa isolates to ceftazidime, meropenem, and gentamicin. A total of 256/834 (30.7%) isolates were MDR. In multivariable analysis, MDR bacteria culture-positive surveillance rectal swabs, previous therapy with aminoglycosides and carbapenems, fluoroquinolone prophylaxis, and time at risk were independently associated with MDR GNB BSI. In conclusion, despite the persistence of a high prevalence of MDR GNB, there was a shift to a reduced use of fluoroquinolone prophylaxis and increased rates of susceptibility to fluoroquinolones in almost all isolates and to almost all antibiotics tested among P. aeruginosa isolates, compared to our previous survey. Fluoroquinolone prophylaxis and previous rectal colonization by MDR bacteria were independent risk factors for MDR GNB BSI in the present study.

1 April 2020 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
MTMario Tumbarello
Mario Tumbarello
FRFrancesca Raffaelli
Francesca Raffaelli
MPMaddalena Peghin
Maddalena Peghin
ALAngela Raffaella Losito
Angela Raffaella Losito
LCLuigi Chirico
Luigi Chirico
MBMatteo Bassetti
Matteo Bassetti

20 January 2024 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
GGGabriele Giuliano
Gabriele Giuliano
SBSara Benedetti
Sara Benedetti
MSMARGHERITA SAMBO
MARGHERITA SAMBO
FPFabio Pierguidi
Fabio Pierguidi
MTMario Tumbarello
Mario Tumbarello

12 November 2024 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
GGGabriele Giuliano
Gabriele Giuliano
MSMargherita Sambo
Margherita Sambo
PCPaola Castellani
Paola Castellani
SBSara Benedetti
Sara Benedetti
FTFrancesca Tarantino
Francesca Tarantino
MTMario Tumbarello
Mario Tumbarello

11 June 2025 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
GGGabriele Giuliano
Gabriele Giuliano
GHGiulia Hankache
Giulia Hankache
MSMARGHERITA SAMBO
MARGHERITA SAMBO
Maria Grazia CusiMaria Grazia Cusi
Maria Grazia Cusi
PLPietro Enea Lazzerini
Pietro Enea Lazzerini
MTMario Tumbarello
Mario Tumbarello
Urinary tract infections (UTI) are among the most common infections in elderly hospitalized patients, often caused by multi-drug resistant (MDR) organisms and characterized by poor clinical outcomes. This study aimed to evaluate the clinical characteristics, microbiology, treatment patterns, and predictors of mortality in elderly hospitalized patients with UTI, with a focus on infections caused by MDR Gram-negative bacteria (MDR-GNB). A retrospective analysis was conducted on 171 patients hospitalized between January 2022 and December 2023 at a large academic hospital in Siena, Italy. Data on demographics, comorbidities, infection characteristics, antimicrobial resistance, treatments, and outcomes were collected. Risk factors for MDR-GNB UTI and predictors of 14-d mortality were identified through univariable and multivariable analyses. Of 171 patients (median age: 82 y), 106 (62.0%) had a catheter-associated UTI, and 105 (61.4%) had a healthcare-associated UTI. MDR-GNB were isolated in 68.4% of cases. Common pathogens included Escherichia coli (74/171, 43.3%), Klebsiella spp. (39/171, 22.8%) and Pseudomonas aeruginosa (33/171, 19.3%). Among Enterobacterales 35.1% were Extended-spectrum β-lactamases-producers, 3.7% carried Klebsiella pneumoniae carbapenemase, and 3.0% metallo-β-lactamases. Overall, the 14-d mortality rate was 12.9%. Predictors of 14-d mortality included septic shock, infections caused by Providencia stuartii, infections caused by New Delhi metallo-β-lactamase-producing K. pneumoniae, and inappropriate empirical antibiotic therapy. UTI significantly affect hospital length of stay and mortality in elderly patients. In the current context, resistance mechanisms including K. pneumoniae carbapenemase and metallo-β-lactamases production, must be considered when managing these infections. Prompt recognition of risk factors for infections caused by MDR organisms and optimized antimicrobial strategies are essential to improve outcomes in this vulnerable population.

19 December 2025 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
GGGabriele Giuliano
Gabriele Giuliano
ALArianna Lippi
Arianna Lippi
MSMargherita Sambo
Margherita Sambo
LDLaerta Dulislami
Laerta Dulislami
MZMarta Zanchi
Marta Zanchi
FMFrancesca Montagnani
Francesca Montagnani